Baiying Bio
Beijing
About Baiying Bio
Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression in mammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $72.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: biointron.com
Industries & Categories
Biotechnology, Outsourcing, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/baiying-bio-56345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.